AI Generated

Jun 30, 2026, 06:43

Haileraguel Hailemichael: Antiphospholipid Syndrome Testing – When Blood Clots Point to an Autoimmune Cause

Haileraguel Hailemichael, Laboratory Project Manager at Micro pharma PLC, shared a post on LinkedIn:

“Antiphospholipid Syndrome (APS) Testing: When Blood Clots Point to an Autoimmune Cause

A young patient develops a deep vein thrombosis (DVT) with no obvious risk factors.

Or a woman experiences recurrent miscarriages despite otherwise normal health.

Could an autoimmune disorder be the underlying cause?

This is where Antiphospholipid Syndrome (APS) testing becomes essential.

What is Antiphospholipid Syndrome (APS)?

APS is an autoimmune disorder in which the body produces antibodies against phospholipid-binding proteins, increasing the risk of:

APS may occur on its own (primary APS) or in association with autoimmune diseases such as Systemic Lupus Erythematosus (SLE).

The Three Main Laboratory Tests

1.Lupus Anticoagulant (LA)

Despite its name, Lupus Anticoagulant is associated with an increased risk of clotting, not bleeding.

It is detected using clot-based coagulation assays.

2.Anticardiolipin Antibodies (aCL)

Measured as:

Persistent moderate-to-high levels support the diagnosis of APS.

3.Anti-β2 Glycoprotein I (Anti-β2GPI)

Measured as:

Highly specific for APS and an important part of the diagnostic criteria.

Real Clinical Scenario

A 32-year-old woman presents with:

Laboratory results:

Lupus Anticoagulant: Positive

Anticardiolipin IgG: Positive

These findings strongly support Antiphospholipid Syndrome (APS) when confirmed with repeat testing.

Important Clinical Pearls

APS testing should not be performed during an acute thrombotic event or while on certain anticoagulants without considering their effect on test interpretation.
A diagnosis of APS requires persistent positivity—the same antibody should be positive on two occasions at least 12 weeks apart, together with an appropriate clinical event.
A single positive antibody result does not confirm APS.
Patients who are ‘triple positive’ (LA and aCL and Anti-β2GPI) are generally at the highest risk for thrombosis and pregnancy complications.

Key Clinical Message

Think about APS testing in patients with:
Unexplained venous or arterial thrombosis at a young age
Recurrent pregnancy loss
Stroke without traditional cardiovascular risk factors
Suspected or confirmed SLE with thrombotic complications
The right antibody test can explain what routine coagulation tests cannot—and may prevent future thrombotic events and pregnancy complications.”

Haileraguel Hailemichael: Antiphospholipid Syndrome Testing - When Blood Clots Point to an Autoimmune Cause